Statins for Graves' orbitopathy (STAGO): a phase 2, open-label, adaptive, single centre, randomised clinical trial - The Lancet Diabetes & Endocrinology
Por um escritor misterioso
Descrição
Graves Disease: Practice Essentials, Pathophysiology, Epidemiology
Effect of dapagliflozin on the rate of decline in kidney function
Current concepts regarding Graves' orbitopathy - Bartalena - 2022
Management of thyroid eye disease: a Consensus Statement by the
Recent advances in graves ophthalmopathy medical therapy: a
The effects of lowering LDL cholesterol with simvastatin plus
American Thyroid Association - Our look at the STAGO trial: What's
PDF) The Role of Oxidative Stress and Therapeutic Potential of
Adverse events associated with unblinded, but not with blinded
Current concepts regarding Graves' orbitopathy - Bartalena - 2022
Rosuvastatin in the Primary Prevention of Cardiovascular Disease
Proposal for Standardization of Primary and Secondary Outcomes in
de
por adulto (o preço varia de acordo com o tamanho do grupo)